Valsartan, Losartan, and Irbesartan Products Liability Litigation

Connecticut Valsartan, Losartan, and Irbesartan Lawsuit Attorneys

Cancer Diagnoses Linked to Contaminated Blood Pressure Medications

Millions of Americans depend on blood pressure medications like valsartan, losartan, and irbesartan to manage hypertension and heart failure, but in 2018, the FDA discovered that many of these medications were contaminated with cancer-causing impurities including NDMA and NDEA. The contamination is believed to have been present for years before discovery, meaning that countless patients may have been unknowingly exposed to carcinogens while trying to manage their cardiovascular health. At BBB Attorneys, we understand the devastating impact of a cancer diagnosis linked to a medication patients trusted for years, and we are committed to helping affected individuals throughout Connecticut pursue accountability and compensation from the pharmaceutical manufacturers responsible.


The valsartan, losartan, and irbesartan lawsuits allege that the manufacturers, including Teva Pharmaceuticals, Novartis, Mylan, and others, failed to properly test their medications for contamination and should have known about the cancer risks associated with NDMA and NDEA. Plaintiffs claim that the manufacturers were negligent in failing to warn patients and healthcare providers about these risks despite being aware of them. Hundreds of lawsuits have been filed against the manufacturers, and the litigation continues to grow as more former users come forward with cancer diagnoses. If you or a loved one developed cancer after taking valsartan, losartan, or irbesartan, BBB Attorneys is prepared to help you understand your legal options and pursue the compensation you deserve.

How Are Valsartan, Losartan, and Irbesartan Linked to Cancer?

The claims involving valsartan, losartan, and irbesartan center on allegations that the medications were contaminated with cancer-causing impurities including NDMA and NDEA, significantly increasing the risk of cancer for long-term users. Many patients took these medications daily for years to manage high blood pressure and heart failure, without any knowledge that the medications could contain potentially dangerous contaminants. Lawsuits allege that the manufacturers concealed or failed to disclose the contamination and continued to sell the medications despite mounting evidence of impurity issues.


Some of the most common cancers linked to contaminated valsartan, losartan, and irbesartan include:

  • Liver cancer
  • Stomach cancer
  • Pancreatic cancer
  • Kidney cancer
  • Colorectal cancer
  • Esophageal cancer
  • Small intestine cancer
  • Other gastrointestinal cancers

A cancer diagnosis linked to contaminated blood pressure medication can be physically, emotionally, and financially devastating for victims and their families. Many individuals face years of intensive treatment including chemotherapy, radiation, surgery, and ongoing medical care, often resulting in significant medical bills, lost wages, and dramatic changes to quality of life. Cancers linked to NDMA exposure, such as pancreatic and liver cancer, are often aggressive and difficult to treat, leading to challenging outcomes for patients and their loved ones. BBB Attorneys understands the seriousness of these injuries and is committed to helping affected individuals and families pursue compensation for medical treatment, lost income, pain and suffering, and other damages caused by contaminated valsartan, losartan, and irbesartan.

Our Clients Come First

At BBB Attorneys, we understand the fear and frustration patients and families feel after learning that a blood pressure medication they took for years was contaminated with cancer-causing impurities. Our firm is committed to standing up for individuals harmed by dangerous and contaminated pharmaceutical products and helping clients navigate complex mass tort and product liability litigation. We are prepared to take on Teva Pharmaceuticals, Novartis, Mylan, and the large corporate defense teams aggressively defending these claims, and we will fight to pursue the accountability and compensation our clients deserve. BBB Attorneys has experience representing individuals in serious injury and product liability matters involving pharmaceutical negligence and inadequate warnings. Because hundreds of valsartan, losartan, and irbesartan lawsuits have been filed and the litigation continues to grow, there is meaningful opportunity to pursue compensation for those harmed by these medications. If you or a loved one developed cancer after taking valsartan, losartan, or irbesartan, contact BBB Attorneys today for a free consultation. There are no upfront costs, and you pay nothing unless we recover compensation for you.

Get a Free COnsultation

Attorneys and paralegals are available 24 hours a day to answer questions regarding your potential case. Call: (203) 562-0900 or fill out this form to reach an attorney.

Contact Us

Proven Results

We've Recovered Millions 

$4,750,000
General Negligence
A client sustained serious burn injuries due to a negligent incident in Connecticut. The injuries required extensive medical treatment and resulted in significant scarring and long-term complications.
$1,750,000
Motor Vehicle Accident
A client was seriously injured in a motor vehicle accident in Connecticut. The collision resulted in multiple severe injuries requiring surgical intervention and long-term medical care.
$1,500,000
Medical Malpractice
A client suffered serious injury as a result of medical negligence in Connecticut. The failure to provide an appropriate standard of care led to a life-threatening medical event.
$1,400,000
General Negligence
A client sustained serious burn injuries due to a negligent incident in Connecticut. The injuries required extensive medical treatment and resulted in significant scarring and long-term complications.
$1,250,000
Motor Vehicle Accident
A client was seriously injured in a motor vehicle accident in Connecticut. The collision resulted in multiple severe injuries requiring surgical intervention and long-term medical care.
$1,125,000
Motor Vehicle Accident
A client was seriously injured in a motor vehicle accident in Connecticut. The collision resulted in multiple severe injuries requiring surgical intervention and long-term medical care.
$975,000
Motor Vehicle Accident
A client sustained injuries in a motor vehicle accident in Connecticut. The collision resulted in injuries requiring ongoing medical treatment and rehabilitation.
$750,000
Slip & Fall
A client suffered serious injuries following a slip and fall incident in Connecticut. The dangerous property condition resulted in multiple fractures requiring immediate medical attention.
$710,000
General Negligence
A client suffered serious injuries as a result of negligent conduct in Connecticut, resulting in life-threatening complications requiring emergency medical care.
$700,000
General Negligence
A client suffered multiple serious injuries as a result of a negligent incident in Connecticut, including traumatic head and orthopedic injuries.
View more

Results depend upon unique facts of each case. We cannot guarantee results such as there in your case.

Two overlapping chat bubbles, one dark blue and one bright blue, with white message lines

YOU MAY HAVE QUESTIONS

What are valsartan, losartan, and irbesartan?
Valsartan, losartan, and irbesartan are angiotensin II receptor blockers (ARBs) commonly prescribed to treat high blood pressure and heart failure. These medications work by blocking the action of a hormone called angiotensin II, which helps regulate blood pressure by relaxing blood vessels. Valsartan was first approved by the FDA in 2012. In 2018, the FDA learned that certain valsartan and related ARB products were contaminated with potential carcinogens, including N-nitrosodimethylamine (NDMA) and N-nitrosodiethylamine (NDEA), leading to widespread recalls.
What are the valsartan lawsuits about?
The valsartan, losartan, and irbesartan lawsuits involve allegations that the medications were contaminated with NDMA, NDEA, and other potential carcinogens linked to multiple types of cancer. Plaintiffs claim that the manufacturers, including Teva Pharmaceuticals, Novartis, Mylan, and others, knew or should have known about the contamination but failed to properly test the medications and failed to warn patients and healthcare providers. Since the 2018 recalls, hundreds of lawsuits have been filed against the manufacturers, and the litigation continues to grow.
What cancers are linked to contaminated valsartan?
Contaminated valsartan, losartan, and irbesartan have been linked to several types of cancer, including liver cancer, stomach cancer, pancreatic cancer, kidney cancer, colorectal cancer, esophageal cancer, and small intestine cancer. NDMA, a primary contaminant, was originally used in rocket fuel production and is known to damage DNA and cause cancer in animals and humans. Studies have suggested that the levels of NDMA found in some contaminated products were significant enough to increase cancer risk in long-term users.
Who may qualify for a valsartan, losartan, or irbesartan lawsuit?
Individuals may qualify for a valsartan, losartan, or irbesartan lawsuit if they took any of these medications between approximately 2012 and 2018 and subsequently developed liver, stomach, pancreatic, kidney, colorectal, esophageal, small intestine, or another cancer linked to NDMA or NDEA exposure. Eligibility depends on the specific medication and manufacturer, the duration of use, the cancer diagnosis, and supporting medical evidence. BBB Attorneys provides a complimentary case review to evaluate eligibility.
What manufacturers were included in the valsartan recall?
Beginning in July 2018, the FDA announced voluntary recalls of various valsartan products due to the presence of NDMA and NDEA. The recall expanded to include certain losartan and irbesartan products. Affected manufacturers included Teva Pharmaceuticals, Novartis, Mylan, Aurobindo, Hetero, Solco Healthcare, Torrent, and others. The contamination is believed to have been present for years before the recall, meaning that millions of patients may have been exposed without their knowledge. Patients who took these medications between 2012 and 2018 should consult with their doctor regarding potential health risks.
We Only Get Paid If You Do

No Win. No Fee.

Start with a free conversation with a lawyer about your potential case. You pay nothing upfront, and nothing at all unless we recover compensation for you. If we don’t win your case, you don’t owe us a fee.

The consultation is free.

We tell you the truth about your case.

No fee unless we recover.